HPR10 The Desirability of Implementing an Outcome-Based Delayed Payment Model for Autologous Gene Therapy Atidarsagene Autotemcel (LIBMELDY®)
Jun 1, 2023, 00:00 AM
10.1016/j.jval.2023.03.1157
https://www.valueinhealthjournal.com/article/S1098-3015(23)01257-3/fulltext
Section Title :
Section Order :
10593
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01257-3&doi=10.1016/j.jval.2023.03.1157